Use this URL to cite or link to this record in EThOS:
Title: The role of Th17 cells in juvenile idiopathic arthritis
Author: Nistala, K.
ISNI:       0000 0004 2730 5154
Awarding Body: University College London (University of London)
Current Institution: University College London (University of London)
Date of Award: 2011
Availability of Full Text:
Access from EThOS:
Access from Institution:
Autoimmune arthritis in childhood, know as juvenile idiopathic arthritis (JIA), has a heterogeneity, ranging from monoarthritis to recalcitrant polyarthritis, making it a model disease in which to study immuno-regulation. Regulatory T cells, key players in peripheral immune homeostasis are enriched in the joints of JIA patients, particularly those with mild arthritis. To test the factors that lead to this enrichment, Treg trafficking was examined in the context of JIA. Synovial Treg showed enhanced chemotaxis to the inflammatory chemokine CCL5, widely detectable within the joint, when compared to Treg from peripheral blood. The trafficking of a related, but highly inflammatory T cell subset, Th17 cells, was also investigated. Th17 cells play a dominant role in murine models of arthritis, yet their contribution to human disease is unknown. The data presented here, showed that IL-17+ CD4 T cells were enriched in the joints of JIA patients, by a CCR6 dependent mechanism and importantly, their frequency correlated with the severity of disease course. The majority of synovial IL-17+ CD4 T cells expressed a cytokine and chemokine receptor phenotype intermediate between Th17 and Th1. Here it was shown that these cells (Th17/1) expressed high levels of both Th17 and Th1 specific transcription factors, RORC2 and T-bet. Modelling the generation of Th17/1 in vitro, Th17 cells ‘converted’ to Th17/1 under conditions which mimicked the disease site, namely low TGFβ and high IL-12 levels. Using CD161, a human Th17 marker, it was shown that synovial Th17/1 cells, and unexpectedly, a large proportion of Th1 cells expressed CD161. This study provided evidence to support a Th17 origin for Th1 cells expressing CD161. In vitro, Th17 cells which converted to a Th1 phenotype maintained CD161 expression, whilst in the joint CD161+ Th1 cells shared features with Th17 cells, with shared T cell receptor clonality and expression of RORC2, although they were IL-17 negative. We propose that Th17 cells may 'convert' to Th17/1 and Th1 cells in human arthritis. Therefore therapies targeting the induction of Th17 cells could also attenuate the Th17/1 and Th1 effector populations within the inflamed joint.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available